The EPIONE device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position, during Computed Tomography (CT) guided percutaneous ablation procedures in the abdomen, performed by physicians trained for CT procedures and performed under general anesthesia with rigid straight instruments such as needles and probes of diameters ranging from 11G to 19G. During the planning phase, the desired instrument and performance is defined relative to the target anatomy. During the guidance phase, the device enables to monitor respiratory patient position prior to instrument advancement. During the assessment phase, the achieved instrument placement and performance are displayed relative to the previously defined plan through an overlay of the pre- and post-treatment image data.

Device Description

The proposed Epione v1.0.2 is a modified version of the Epione predicate device as was cleared under 510(k) K211645. Aside from the modifications that are summarized further below, the Epione v1.0.2 is the same as the predicate as follows.

The EPIONE device v1.0.2 is a user controlled, stereotactic accessory device intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) quided percutaneous procedures.

During the planning phase, the desired instrument placement and performance is defined relative to the tarqet anatomy. During the quidance phase, the device enables to monitor respiratory levels and verify patient position prior to instrument. During the assessment phase, the achieved instrument placement and performance are displayed relative to the previously defined plan through an overlay of the pre- and post-treatment image data.

The device is indicated for use with rigid straight instruments such as needles, and applicators (cryoprobes, electrodes, and antennas), used in CT-guided interventional procedures performed by physicians trained for CT procedures on organs and anatomical structures in the abdomen.

The EPIONE device v1.0.2 consists in the following components: Robot cart, Display cart, Navigation cart, EPIONE software, EPIONE instruments (Needle guide, Patient reference, Short Navigation probe).

The modifications include:

expanding its ablation procedure indications to organs in the abdomen as compared to ablation procedures only on the liver in the Epione predicate,
the addition of a new software functionalities to facilitate multi-needle planning that include configurable multiple needle array configurations for simultaneous needle group planning as compared to the planning of one needle at a time in a sequential manner in the Epione predicate,
the addition of post-procedure imaging software tools to measure the post-procedure ablated zones as compared to only visual assessment in the Epione predicate, and
the addition of an alternate shortened version of the navigation probe as compared to original longer version in the Epione predicate. This short navigation probe replaces the longer original navigation probe.

AI/ML Overview

Here's a breakdown of the acceptance criteria and the study details for the Epione v1.0.2 device, based on the provided FDA 510(k) summary:

Acceptance Criteria and Reported Device Performance

The provided document primarily focuses on demonstrating substantial equivalence to predicate devices rather than setting explicit numerical acceptance criteria for a new, unique performance claim. However, the non-clinical tests re-performed from the predicate and the clinical study aim to demonstrate that the device performs equivalently to the predicates.

The implied acceptance criterion is that the device should be as safe and effective in achieving its intended use as in the predicates. The reported device performance is that it meets this implied criterion based on the conducted studies.

Acceptance Criteria (Implied)	Reported Device Performance
Overall System Accuracy equivalent to predicate	Overall System Accuracy Tests were re-performed from the EPIONE predicate to verify no software implementation errors were introduced, implicitly showing equivalent performance. The positional accuracy testing using the new shorter navigation probe was re-performed and verified that the static positioning accuracy was maintained as in the Epione predicate.
Respiratory Monitoring Effectiveness equivalent to predicate	Respiratory Monitoring Effectiveness Tests were re-performed from the EPIONE predicate to verify no software implementation errors were introduced, implicitly showing equivalent performance.
Usability for new multi-needle feature safe and effective	Usability Testing (accordance with IEC 62366-1:2015 and FDA guidance) was re-performed to demonstrate the new multi-needle feature is safe and effective.
Software functions safe and effective (correct implementation)	Software design and verification and validation testing completed in compliance with FDA guidance and IEC 62304 Standard to establish safety and effectiveness, including correct implementation of software changes.
In-vivo equivalence in safety and effectiveness for abdominal procedures as compared to predicates	Interim clinical study results with 33 patients demonstrated in-vivo equivalence in safety and effectiveness for CT-guided procedures in abdominal organs, compared to predicates.

Study Information:

2. Sample Size Used for the Test Set and Data Provenance

Test Set Sample Size:
- Non-Clinical (Bench) Testing: The document does not specify a numerical sample size for the "Overall System Accuracy Tests," "Respiratory Monitoring Effectiveness Tests," or "positional accuracy testing." It states these were "re-performed" from the predicate.
- Usability Testing: Not specified, but re-performed.
- Clinical Study: 33 patients (interim data).
Data Provenance:
- Non-Clinical Tests: In-vitro (bench testing).
- Usability Testing: Re-performed.
- Clinical Study: Ongoing clinical study in France (prospective data).

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

The document does not specify the number of experts or their qualifications for establishing ground truth in the non-clinical or usability testing. These tests likely rely on standardized measurements and expert evaluation of safety and effectiveness, but specific details are not provided.
For the clinical study, the ground truth for "in-vivo equivalence in safety and effectiveness" is established through physician-performed procedures and patient outcomes, but the number of adjudicating experts or their detailed qualifications for assessing the clinical data are not explicitly mentioned. The study is non-interventional, investigating device performance in procedures performed by "physicians trained for CT procedures."

4. Adjudication Method for the Test Set

The document does not specify an explicit adjudication method (e.g., 2+1, 3+1, none) for any of the tests, including the clinical study. It states that the clinical study investigated the performance of the device.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

A MRMC comparative effectiveness study is not explicitly mentioned or described in the provided text. The clinical study is a non-interventional study investigating the performance of the device itself, not comparing human readers with and without AI assistance.

6. Standalone (Algorithm Only) Performance Study

The device is described as a "user-controlled, stereotactic accessory" with a robotic arm and software components, indicating a human-in-the-loop system. While software verification and validation were performed, a standalone (algorithm only) performance study in the sense of an independent diagnostic algorithm without human interaction is not described. The software functions assist the physician.

7. Type of Ground Truth Used

Non-Clinical Tests:
- Overall System Accuracy & Positional Accuracy: Likely based on objective physical measurements and comparisons to known standards or established predicate device performance.
- Respiratory Monitoring Effectiveness: Likely based on objective physiological measurements.
Usability Testing: Based on user interaction, feedback, and demonstration of safe and effective use by intended users.
Clinical Study: "In-vivo equivalence in safety and effectiveness" is the ground truth assessed. This would involve clinical outcomes, procedure success rates, safety endpoints, and potentially expert assessment of procedural metrics, though details are not provided.

8. Sample Size for the Training Set

The document does not provide information about a specific training set size. The EPIONE device is a robotic surgical assistance system, and while it has software, it's not primarily an AI/ML image interpretation algorithm that would typically have a distinct image-based training set described in this context. The software development likely involved extensive internal testing and refinement, but a dedicated "training set" in the context of machine learning model development is not detailed here.

9. How the Ground Truth for the Training Set Was Established

As a training set is not explicitly identified or described in the context of AI/ML model training, the method for establishing its ground truth is also not provided.

Summary

{0}------------------------------------------------

May 3, 2023

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Quantum Surgical SAS % Elise Lagacherie Quality Assurance & Regulatory Affairs Director ZAC Eureka 1000 Rue du Mas de Verchant 34000 Montpellier FRANCE

Re: K223758

Trade/Device Name: Epione Regulation Number: 21 CFR 892.1750 Regulation Name: Computed Tomography X-Ray System Regulatory Class: Class II Product Code: JAK Dated: March 31, 2023 Received: April 3, 2023

Dear Elise Lagacherie:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

{1}------------------------------------------------

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Lu Jiang

Lu Jiang, Ph.D. Assistant Director Diagnostic X-ray Systems Team DHT8B: Division of Radiological Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K223758

Device Name EPIONE

Indications for Use (Describe)

Type of Use (Select one or both, as applicable)
-------------------------------------------------	--

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the logo for Quantum Surgical. The logo consists of an orange geometric shape on the left and the words "QUANTUM surgical" on the right. The word "QUANTUM" is in orange, and the word "surgical" is in gray.

K223758

510(k) SUMMARY

Date prepared: 02, May 2023

Submitter

Quantum Surgical SAS

1000 rue du mas de Verchant 34000 Montpellier France

Contact Person:

Elise Lagacherie, Quality & Regulatory Affairs Director e.lagacherie@quantumsurgical.com

Device:

Name of Device: EPIONE Common or Usual Name: Computer assisted Surgical System. Classification Name: Computed tomography X-ray system (21 CFR 892.1750) Requlatory Class: II Product Code: JAK

Primary Predicate Device

EPIONE® (JAK, K211645), Quantum Surgical SAS

Secondary Predicate Device

MAXIO (JAK, K132108), Perfint Healthcare Pvt. Ltd.

Note : This proposed new version for EPIONE, will be referred to as "EPIONE v1.0.2" to differentiate it from the original EPIONE predicate.

Device Description

The EPIONE device v1.0.2 consists in the following components:

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image contains the logo for Quantum Surgical. The logo consists of an orange hexagon with a stylized "Q" shape formed by a thick orange line wrapping around the hexagon. To the right of the hexagon is the text "QUANTUM" in orange, stacked above the word "surgical" in gray. The logo appears to be for a medical or surgical company.

Robot cart	This mobile equipment can be moved in and out of the intervention room and is positioned next to the patient. The cart carries a robotic arm including a force sensor assembly allowing handguiding of the robotic arm by the user. The robotic arm movements are enabled by the user using a footswitch. The robot cart also embeds the electronic systems required to power and operate the robot arm
Display cart	This mobile equipment can be moved in and out of the intervention room and is positioned next to the operator. The cart carries a touchscreen to operate the system.
Navigation cart	This mobile equipment can be moved in and out of the intervention room and is positioned next to the table. The cart carries a navigation camera.
EPIONE software	A software provides the step-by-step workflow assistance for intervention planning and intraoperative positioning of the robotic arm for instruments placement and post-operative assessment.
EPIONE instruments	Needle guidePatient referenceShort Navigation probe

The modifications include :

expanding its ablation procedure indications to organs in the abdomen as compared to ablation procedures only on the liver in the Epione predicate,
the addition of a new software functionalities to facilitate multi-needle planning that include configurable multiple needle array configurations for simultaneous needle group planning as compared to the planning of one needle at a time in a sequential manner in the Epione predicate,
the addition of post-procedure imaging software tools to measure the post-procedure ablated zones as compared to only visual assessment in the Epione predicate, and
the addition of an alternate shortened version of the navigation probe as compared to original longer version in the Epione predicate. This short navigation probe replaces the longer original navigation probe.

EPIONE v1.0.2 Indications for Use

The EPIONE® device is a user controlled, stereotactic accessory intended to assist in the planning and manual advancement of one or more instruments, as well as in verification of instrument position during Computed Tomography (CT) guided percutaneous ablation procedures in the abdomen, performed by physicians trained for CT procedures and performed under general anesthesia with rigid straight instruments such as needles and probes of diameters ranging from 11G to 19G.

During the planning phase, the desired instrument placement and performance is defined relative to the target anatomy. During the guidance phase, the device enables to monitor respiratory levels and verify patient position prior to instrument advancement. During the assessment phase, the achieved instrument placement and performance are displayed relative to the previously defined plan through an overlay of the pre- and post-treatment image data.

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image shows the logo for Quantum Surgical. The logo consists of an orange geometric shape resembling a stylized "Q" on the left, followed by the words "QUANTUM" in orange and "surgical" in gray on the right. The geometric shape is made up of connected lines and angles, creating a modern and abstract design.

Comparison with the primary and secondary predicate devices

	EPIONE v1.0.2	EPIONE	MAXIO
	Proposed device	Primary Predicate device	Secondary Predicate device
Intended use /Indication for Use	The EPIONE® device is a user controlled,stereotactic accessory intended to assist in theplanning and manual advancement of one ormore instruments, as well as in verification ofinstrument position during ComputedTomography (CT) guided percutaneousablation procedures in the abdomen,performed by physicians trained for CTprocedures and performed under generalanesthesia with rigid straight instrumentssuch as needles and probes of diametersranging from 11G to 19G.During the planning phase, the desiredinstrument placement and performance isdefined relative to the target anatomy. Duringthe guidance phase, the device enables tomonitor respiratory levels and verify patientposition prior to instrument advancement.During the assessment phase, the achievedinstrument placement and performance aredisplayed relative to the previously defined planthrough an overlay of the pre- and post-treatment image data.	The EPIONE device is a user controlled,stereotactic accessory intended to assist in theplanning and manual advancement of one ormore instruments, as well as in verification ofinstrument position during ComputedTomography (CT) guided percutaneousprocedures.During the planning phase, the desiredinstrument placement and performance isdefined relative to the target anatomy.During the guidance phase, the device enables tomonitor respiratory levels and verify patientposition prior to instrument advancement.During the assessment phase, the achievedinstrument placement and performance aredisplayed relative to the previously defined planthrough an overlay of the pre- and post-treatment image data.The device is indicated for use in liver ablationprocedures, under general anesthesia withrigid straight instruments such as needles,and probes of diameters ranging from 11G to19G by physicians trained for CT procedures.	MAXIO is a user controlled, stereotacticaccessory intended to assist in the planning andmanual advancement of one or moreinstruments during Computed Tomography (CT)guided percutaneous procedures.MAXIO permits physician verification of patientposition prior to needle advancement andmonitoring of respiratory levels during theprocedure.Image registration and overlay tools available inMAXIO are intended to provide guidance to theuser during planning and instrument placement.MAXIO is indicated for use with rigid straightinstruments such as needles and probes used inComputed Tomography (CT) guidedpercutaneous interventional proceduresperformed by physicians trained for CTprocedures on organs and anatomicalstructures in the thorax, abdomen and pelvis.
Patient AnesthesiaConditions	For use under general anesthesia conditions	For use under general anesthesia conditions	For use under local and general anesthesiaconditions
Intra-interventionalPlanning	Physician defines trajectories per an entry pointand a target point on CT images.	Physician defines trajectory per an entry pointand a target point on CT images.	Physician defines trajectory per an entry pointand a target point on CT images.
Interventionalinstruments	Rigid straight interventional instruments such asneedles, probes for biopsy, ablation and drainagefrom 11G to 19G	Rigid straight interventional instruments such asneedles, probes for biopsy, ablation and drainagefrom 11G to 19G	Rigid straight interventional instruments such asneedles, probes for biopsy, ablation and drainagefrom 11G to 21G
	EPIONE v1.0.2Proposed device	EPIONEPrimary Predicate device	MAXIOSecondary Predicate device
Needleconfiguration andperformance	• Needle selection amongst a list of predefinedneedles• Manufacturer defined performances (e.g.ablation zones)• User-defined performances (tools forassessment of ablation zones)	• Needle selection among a list of predefinedneedles• Manufacturer defined performances (e.g.ablation zones)	• Needle selection amongst a list of predefinedneedles• Manufacturer defined performances (e.g.ablation zones).• User-defined performances (tools forassessment of ablation zones).
Needle guidance	• Robotic arm with needle guide is positionedon the desired trajectories as was planned onthe intra-interventional CT images.• Instrument (e.g. needle) is then manuallyadvanced through the guide on the plannedtrajectory.	• Robotic arm with needle guide is positionedon the desired trajectory as was planned onthe intra-interventional CT images.• Instrument (e.g. needle) is then manuallyadvanced through the guide on the plannedtrajectory.	• Robotic arm with needle guide instrument ispositioned on the desired trajectory as wasplanned on the intra-interventional CT images.• Instrument (e.g. needle) is then manuallyadvanced through the guide on the plannedtrajectory.
Patientregistration	Automatic patient location to image registrationper array of markers on a patient referenceinstrument placed on the patient's skin andincluded in the CT-scan images and which arelocated using an optical tracking system.	Automatic patient location to image registrationper array of markers on a patient referenceinstrument placed on the patient's skin andincluded in the CT-scan images and which arelocated using an optical tracking system.	The location of the robotic workstation is locatedto a fixed established reference position relativeto the CT scan and bed per the use of a dockingmat and calibration process performed duringthe initial workstation installation.
PatientRegistrationverification	The navigation probe is pointed to pre-identifiedpoints on the patient (skin markers) to verify theirrelative locations.	The navigation probe is pointed to pre-identifiedpoints on the patient (skin markers) to verify theirrelative locations.	Skin markers are placed on the patient andincluded in the CT-scan and located whenplanning. Then before needle placement, it isverified using a laser system that the patient hasnot moved by verifying that the locations of theskin markers are still in the same location aswhen scanned. In addition, table markers are alsoused to verify also per a laser cross-hairs that therelative locations of the CT scan and robotworkstation have not changed from the originalinstallation.
RespiratoryMotionManagement	Respiratory motion control using breath-holdMeasurement of apnea reference level during theintra-interventional planning CT imaging.Live display of respiratory level using the markers/ patient reference placed on the patient andvisual comparison with the reference level duringneedle guidance	Respiratory motion control using breath-holdMeasurement of apnea reference level during theintra-interventional planning CT imaging.Live display of respiratory level using the markers/ patient reference placed on the patient andvisual comparison with the reference level duringneedle guidance	Respiratory motion control using breath-hold.Measurement of apnea reference level during theintra-interventional planning CT imaging.Live display of respiratory level using arespiratory belt mounted on the patient(Medspira Breath-Hold for Interventionalneedle guidance)
	EPIONE v1.0.2Proposed device	EPIONEPrimary Predicate device	MAXIOSecondary Predicate device
Intra-interventionalverification	Verification CT Image registration with planning CT to compare achieved needle position to planned needle trajectory	Verification CT Image registration with planning CT to compare achieved needle position to planned needle trajectory	Radiology).and visual comparison with the reference level during needle guidance.Verification CT Image registration with planning CT to compare achieved needle position to planned needle trajectory
Post-procedureverification	Register intra-interventional CT series with post procedure CT series to display planned target position on Post-procedure CT image.	Register intra-interventional CT series with post procedure CT series to display planned target position on Post-procedure CT image.	Register intra-interventional CT series with post procedure CT series to display planned target position on Post-procedure CT image.Also includes tools to segment ablated zone in post-ablation images, and to register pre and post ablation image, to perform a visual assessment of the ablation.

{6}------------------------------------------------

Image /page/6/Picture/0 description: The image contains the logo for Quantum Surgical. The logo consists of an orange icon on the left and the text "QUANTUM surgical" on the right. The icon is an abstract shape that resembles the letter "Q". The word "QUANTUM" is in orange, and the word "surgical" is in gray.

{7}------------------------------------------------

Image /page/7/Picture/0 description: The image contains the logo for Quantum Surgical. The logo consists of an orange stylized letter "Q" on the left, with the words "QUANTUM" in orange and "surgical" in gray to the right of the "Q". The "Q" is made up of a hexagon shape with a line extending from the bottom left corner.

The comparisons between the EPIONE v1.0.2 and EPIONE and MAXIO predicates determined that:

The general intended use is unchanged with the proposed modifications and is equivalent to that of the EPIONE and Maxio predicates.
· The extension of the anatomical/organ anatomy in the EPIONE v1.0.2 to include procedures on organs and structures in the abdoninal area, as compared to procedures on the live in the EPONE predicate, is within the indications of the secondary in indications was supported with clinical data showing equivalent performance to the Maxio predicate.
· The EPIONE v1.0.2 has equivalent technological characters. The new software multi-needle and ablation assessment features and the new shorter Navigation Probe instrument include modifications without impacting the overal technology intended use, or indications for use. The added multi-needle are also similarly provided in the Maxio predicate. These changes do not raise different questions of safety or effectiveness as compared to the predicates.

{8}------------------------------------------------

Summary of Non-Clinical Performance Data:

To establish substantial equivalence with predicates and to verify that the EPIONE v1.0.2 will perform safely and effectively per its intended use equivalently to the EPIONE predicate:

. The following in-vitro performance tests were repeated from the EPIONE predicate to verify that no software implementation errors were introduced:
- o Overall System Accuracy Tests,
- o Respiratory Monitoring Effectiveness Tests and
. The positional accuracy testing was re-performed as in the Epione predicate in accordance with the ASTM F2554-10 Standard Practice for Measurement of Positional Accuracy of Computer Assisted Surgical Systems to re-verify that the static positioning accuracy of the device when using the new shorter navigation probe was maintained as in the Epione predicate with the longer navigation probe.
. Usability Testing, in accordance to IEC 62366-1:2015 and the FDA guidance document Applying Human Factors and Usability Engineering to Medical Devices was re-performed similarly as the EPIONE predicate to demonstrate that the new multi-needle feature is safe and effective for the intended users, uses and use environments.

Additionally, Software design and verification and validation testing was completed similarly as in the Epione predicate to establish the device's safety and effectiveness including verifying the correct implementation of the various software changes in compliance to the FDA guidance "Content of Premarket Submissions for Software Contained in Medical Devices", the new draft guidance "Content of Premarket Submissions for Device Software Functions", the IEC 62304 Standard "Medical Device Software – Life Cycle Process", as well as FDA cybersecurity premarket quidance document "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices".

Clinical study

This includes the interim data from an ongoing clinical in France. The main objective of this noninterventional study is to investigate the performance of EPIONE v1.0.2 as used for CT-guided procedures in different organs of the abdomen. The interim results of this study with the first 33 patients demonstrate the in-vivo equivalence in safety and effectiveness of the EPIONE v1.0.2 for procedures in the abdomen as compared to the predicates.

Conclusions

The EPIONE v1.0.2 was demonstrated to have the same overall intended use as the predicates with its expanded indication from its Epione predicate being within that of the Maxio predicate. The information supports that it has equivalent technological characteristics with the predicates that do not raise different questions of safety and effectiveness. The testing includes bench testing, animal, and clinical testing demonstrating that the device should be as safe and effective in achieving its intended use as in the predicates. The EPIONE device v1.0.2 is therefore substantially equivalent to the predicates devices.

Regulation Number and Section

§ 892.1750 Computed tomography x-ray system.

(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.